Sign in
CompletedNo phase

Study on the Surgical Strategy of Corneal Endothelial Protection for Hard Nuclear Cataract Patients

Key facts

Who runs it
Eye & ENT Hospital of Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
207 people enrolled
Started
10 Aug 2022
Ended
1 Mar 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • combined burst mode
  • torsional mode
Record updated
28 May 2025

Who can take part

Age
50 years to 95 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • patients with age-related cataracts that were only classified by Emery-Little as nuclear hardness grade III-V
  • encompassed a minimum dilated pupil diameter of 7 mm or above, as well as a corneal endothelial cell count exceeding 1200/mm\^2
  • Corneal morphology is normal and clear
  • Informed consent is required prior to enrollment

Who cannot take part

  • Exclude those with previous intraocular surgery
  • Those with white cataracts, histories of eye surgery, and eye diseases such as corneal pathology, uveitis, Fuchs\' dystrophy, and glaucoma were excluded
  • Exclude those with comorbid ocular and systemic diseases that affect corneal endothelial cell function

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this study, we compared two types of phacoemulsification commonly used in cataract surgery to evaluate their effect on the prognosis of patients with hard nuclei. This will provide a theoretical basis for selecting a more appropriate cataract surgery modality in practice in hard-nucleus patients.

The 2 groups in the trial

  • Combined burst modeTreatment being tested

    combining the torsional and vertical ultrasound under burst mode(Burst Tor+ Burst US) Phacoemulsification mode Brust mode Torsional amplitude 0-90% Longitudinal power 40% Infusion system Gravity fed Bottle height 50-80 cm Vacuum 360 mmHg Aspiration flow rate 30 cm3/min Burst duration 70 ms Off time 50 ms

  • torsional modeExisting treatment, for comparison

    torsional mode under continues mode (Linear Tor) Phacoemulsification mode Continuous mode Torsional amplitude 0-90% Longitudinal power 0 Infusion system Gravity fed Bottle height 50-80 cm Vacuum 360 mmHg Aspiration flow rate 30 cm3/min Burst duration - Off time -

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Combined Burst Mode Versus Torsional Mode Phacoemulsification for Patients With Hard Nuclear Cataract: A Randomized Control Study
Publications
Record updated
28 May 2025